Abstract:Given that TLRs and sphingosine-1-phosphate (S1P) are key players in inflammation, we explored the potential interplay between TLRs and S1P in the adhesion/inflammatory pathways in primary human endothelial cells. As determined by Western blot and flow cytometry, cells treated with LPS (a TLR4 ligand) and S1P showed significantly enhanced expression of adhesion molecules such as ICAM-1 and E-selectin compared with the effect of either ligand alone. Cell-type differences on E-selectin upregulation were observed. In contrast, no cooperation effect on ICAM-1 or E-selectin was observed with a TLR2/TLR1 ligand. Consistent with an increase in adhesion molecule expression, endothelial cell treatment with LPS plus S1P significantly enhanced adhesion of PBMCs under shear stress conditions compared with the effect of either ligand alone and exhibited comparable levels of cell adhesion strength as those after TNF-a treatment. Moreover, LPS and S1P cooperated to increase the expression of proinflammatory molecules such as IL-6, cyclooxygenase-2, and prostacyclin, as determined by ELISA and Western blot. The analysis of signaling pathways revealed the synergistic phosphorylation of ERK upon LPS plus S1P treatment of HUVEC and human aortic endothelial cells and cell-type differences on p38 and NF-kB activation. Moreover, pharmacological and small interfering RNA experiments disclosed the involvement of S1P 1/3 and NF-kB in the cooperation effect and that cell origin determines the S1P receptors and signaling routes involved. Sphingosine kinase activity induction upon LPS plus S1P treatment suggests S1P– Sphingosine kinase axis involvement. In summary, LPS and S1P cooperate to increase proinflammatory molecules in endothelial cells and, in turn, to augment leukocyte adhesion, thus exacerbating S1P-mediated proadhesive/proinflammatory properties. S phingosine-1-phosphate (S1P) is a bioactive lipid mediator that mediates a wide spectrum of cell functions in both intracellular and extracellular compartments, which includes proliferation, migration, differentiation, angiogenesis, and lymphocyte trafficking (1–3). Many of the actions of S1P are mediated by the activation of receptors, initially known as endo-thelial differentiation genes and now designated as S1P 1–5 , which are high-affinity receptors coupled to G proteins (a io , a q , or a 12/13) that trigger the activation of multiple signals leading to specific cell responses (4). In addition, S1P can play an important role as a second messenger during inflammation (2). Accumulating evidence suggests an important role of S1P in the regulation of the immune system and the vascular system (2, 5). The S1P–S1P-receptor signaling axis has been implicated in a variety of pathophysiological conditions and diseases such …

Tumor Necrosis Factor-Alpha Induces Adhesion Molecule Expression Through the Sphingosine Kinase Pathway.

Activation of Sphingosine Kinase by Tumor Necrosis Factor-α Inhibits Apoptosis in Human Endothelial Cells

Effects of Antioxidants and Nitric Oxide on TNF-α-induced Adhesion Molecule Expression and NF-κB Activation in Human Dermal Microvascular Endothelial Cells

Effects of antioxidants and NO on TNF-α-induced adhesion molecule expression in human pulmonary microvascular endothelial cells

Tanshinone II A Attenuates TNF-α-Induced Expression of VCAM-1 and ICAM-1 in Endothelial Progenitor Cells by Blocking Activation of NF-κB.

Sphingosine Kinase Interacts with TRAF2 and Dissects Tumor Necrosis Factor-α Signaling

Direct Activation of TACE-Mediated Ectodomain Shedding by P38 MAP Kinase Regulates EGF Receptor-Dependent Cell Proliferation

Activation of nuclear factor-κB pathway is responsible for tumor necrosis factor-α-induced up-regulation of endothelin B2 receptor expression in vascular smooth muscle cells in vitro.

Apolipoprotein M and sphingosine-1-phosphate complex alleviates TNF-α-induced endothelial cell injury and inflammation through PI3K/AKT signaling pathway

The crosstalk between neuropilin-1 and tumor necrosis factor-α in endothelial cells

Jnk/Ap-1 Pathway is Involved in Tumor Necrosis Factor-Alpha Induced Expression of Vascular Endothelial Growth Factor in Mcf7 Cells

Human vascular smooth muscle cells. Target for and source of tumor necrosis factor.

TNF-alpha induction of lipolysis is mediated through activation of the extracellular signal related kinase pathway in 3T3-L1 adipocytes

Chronic Increases in Sphingosine Kinase-1 Activity Induce A Pro-Inflammatory, Pro-Angiogenic Phenotype in Endothelial Cells

Role of Isoprenylcysteine Carboxyl Methyltransferase in Tumor Necrosis Factor-Alpha Stimulation of Expression of Vascular Cell Adhesion Molecule-1 in Endothelial Cells.

Etk/Bmx Transactivates Vascular Endothelial Growth Factor 2 and Recruits Phosphatidylinositol 3-Kinase to Mediate the Tumor Necrosis Factor-Induced Angiogenic Pathway.

TNF-α Induces Lnk Expression Through PI3K-Dependent Signaling Pathway in Human Umbilical Vein Endothelial Cells

The Matricellular Protein CCN1 Regulates TNF‐α Induced Vascular Endothelial Cell Apoptosis

Leukocyte Adhesion in Endothelial Cells Induce Inflammatory Molecules and Sphingosine-1-Phosphate Cooperate To Lipopolysaccharide

Cell adhesion tunes inflammatory TPL2 kinase signal transduction

Lipopolysaccharide and sphingosine-1-phosphate cooperate to induce inflammatory molecules and leukocyte adhesion in endothelial cells